DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A
Lotte Coelmont(Rega Institute for Medical Research), Johan Neyts(Rega Institute for Medical Research), Precious Lim(Scripps Research Institute), Ralf Bartenschlager(German Cancer Research Center), Guy Lippens(Centre National de la Recherche Scientifique), Michael Bobardt(Scripps Research Institute), Inge Vliegen(Rega Institute for Medical Research), Jan Paeshuyse(Rega Institute for Medical Research), Philippe Gallay(Scripps Research Institute), Anne–Mieke Vandamme(Rega Institute for Medical Research), Carola Berger(Heidelberg University), Joke Snoeck(Rega Institute for Medical Research), Xavier Hanoulle(Centre National de la Recherche Scientifique), Grégoire Vuagniaux(Debiopharm (Switzerland)), Udayan Chatterji(Scripps Research Institute)
Cited by 183
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
The lipid droplet is an important organelle for hepatitis C virus production
|Nature Cell Biology|2007|1.2k
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
|Proceedings of the National Academy of Sciences|2006|712
Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication
|PLoS Pathogens|2012|514
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483